Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
Health Technology » Pharmaceuticals Major
|JNJ||Johnson & Johnson||0.05%||163.30||0.7%||$1331.47m|
|LLY||Eli Lilly & Co.||0.74%||324.00||1.1%||$1075.83m|
|BMY||Bristol-Myers Squibb Co.||-0.03%||70.52||1.0%||$772.56m|
|MRK||Merck & Co., Inc.||0.32%||87.84||0.7%||$712.72m|
|ALNY||Alnylam Pharmaceuticals, Inc.||0.00%||196.79||8.2%||$217.39m|
|GBT||Global Blood Therapeutics, Inc.||0.00%||68.48||5.4%||$191.16m|
|IDXX||IDEXX Laboratories, Inc.||1.12%||340.46||3.9%||$186.35m|
|ATXI||Avenue Therapeutics, Inc.||28.76%||14.82||0.0%||$179.37m|
|HZNP||Horizon Therapeutics Plc||0.00%||64.26||5.4%||$173.65m|
|SRPT||Sarepta Therapeutics, Inc.||0.00%||109.94||12.4%||$136.73m|
Horizon Therapeutics Plc is a biopharmaceutical company, which is engaged in the research, development, and marketing of pharmaceutical products. It operates through the Orphan and Inflammation segments. The Orphan segment consists of medicines KRYSTEXXA, RAVICTI, PROCYSBI, ACTIMMUNE, BUPHENYL, QUINSAIR, and RAYOS. The Inflammation segment comprises medicines PENNSAID 2%, DUEXIS, and VIMOVO. The company was founded in 2008 and is headquartered in Dublin, Ireland.